UCL researchers are working to others to develop an AI tool to determine who may be at greater risk of damage from chemotherapy. They'd like to hear from patients/carers who've experienced kidney or liver damage during treatment if they're available for a workshop next week.
More details here...
Patient/carer Involvement Opportunity
AI Product Development Workshop
Thursday 9th March 2023. 1300 – 1500 hrs (1 – 3pm)
Venue 170 Tottenham Court Road, London W1T 7HA
Virtual dial in will be an option – details will be sent to those who express interest
Opportunity:
Patient/carer reps with experience of chemotherapy who had kidney or liver damage are sought to
join key stakeholders in a workshop to evaluate an AI tool to predict such toxicities.
Background:
Chemotherapy is the treatment of disease using chemical substances, commonly used to treat
cancer. Chemotherapy is often toxic to normal cells and two common risks relate to kidney and liver
damage.
Affected patients may require delays or changes to treatment even stopping treatment.
Whilst <10% of patients will experience kidney or liver damage, current best practice requires all
patients to be monitored with regular blood testing.
UCLPartners is assisting in the evaluation of an AI tool to predict kidney and liver damage which
would save unnecessary trips for lower risk patients alongside prioritisation of higher risk patients.
The development of this tool will deliver a proof of concept application for eventual use in live
clinical practice.
Workshops: As part of the application development, UCLPartners is seeking key stakeholders with
clinical, operational commissioning, and/or lived experience in cancer pathways.
Previous experience managing or experience with being treated for kidney and liver damage
associated with chemotherapy would be beneficial.
The stakeholders would take part in an initial 90 minute guided discussion exploring a number of
topics including but not limited to:
- Current chemotherapy pathways
- Barriers and enablers to AI tools in the NHS
- Estimated impact on current practice
A second workshop would take place following the AI tool’s development where the group would
explore previous discussions and how the system has worked in a real world setting.
Honorarium for time in line with UCL PPIE policy and reasonable travel expenses reimbursed if
attending in person
If interested, please contact :-
Gurth Fernando (he/him)
Innovation Manager
gurth.fernando@uclpartners.com | uclpartners.com | @uclpartners
UCLPartners, 3rd Floor, 170 Tottenham Court Road, London W1T 7HA
C T Scan
New on here
My Mum part 4
Chemotherapy Cycle Two Weeks 2 and 3 
Have you had a good experience with your lung cancer nurse specialist?
